KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Sales (2018 - 2025)

Castle Biosciences' Return on Sales history spans 7 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales fell 14.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.07%, down 13.0%, while the annual FY2025 figure was 0.07%, 13.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.03% at Castle Biosciences, down from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.11% in Q4 2024 and bottomed at 0.92% in Q1 2022.
  • The 5-year median for Return on Sales is 0.15% (2023), against an average of 0.25%.
  • The largest annual shift saw Return on Sales plummeted -73bps in 2022 before it skyrocketed 66bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.53% in 2021, then dropped by -1bps to 0.54% in 2022, then surged by 93bps to 0.04% in 2023, then surged by 385bps to 0.11% in 2024, then plummeted by -124bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Return on Sales are 0.03% (Q4 2025), 0.01% (Q3 2025), and 0.05% (Q2 2025).